CN101627973A - 一种醋酸钙片及其制备方法 - Google Patents
一种醋酸钙片及其制备方法 Download PDFInfo
- Publication number
- CN101627973A CN101627973A CN200910094800A CN200910094800A CN101627973A CN 101627973 A CN101627973 A CN 101627973A CN 200910094800 A CN200910094800 A CN 200910094800A CN 200910094800 A CN200910094800 A CN 200910094800A CN 101627973 A CN101627973 A CN 101627973A
- Authority
- CN
- China
- Prior art keywords
- calcium acetate
- tablet
- polyvinylpolypyrrolidone
- magnesium stearate
- acetate tablet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000011092 calcium acetate Nutrition 0.000 title claims abstract description 53
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 title claims abstract description 52
- 239000001639 calcium acetate Substances 0.000 title claims abstract description 52
- 229960005147 calcium acetate Drugs 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 30
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 15
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 15
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 claims abstract description 15
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims abstract description 15
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims abstract description 15
- 239000011734 sodium Substances 0.000 claims abstract description 15
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 10
- 201000005991 hyperphosphatemia Diseases 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- 239000008187 granular material Substances 0.000 claims description 18
- 229940079593 drug Drugs 0.000 claims description 7
- 238000012360 testing method Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 239000007779 soft material Substances 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 5
- 229920002472 Starch Polymers 0.000 abstract description 4
- 239000008107 starch Substances 0.000 abstract description 4
- 235000019698 starch Nutrition 0.000 abstract description 4
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 12
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 description 6
- 239000011574 phosphorus Substances 0.000 description 6
- 229910052698 phosphorus Inorganic materials 0.000 description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 235000015424 sodium Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 208000037147 Hypercalcaemia Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000000148 hypercalcaemia Effects 0.000 description 2
- 208000030915 hypercalcemia disease Diseases 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 238000013341 scale-up Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- MWKXCSMICWVRGW-UHFFFAOYSA-N calcium;phosphane Chemical compound P.[Ca] MWKXCSMICWVRGW-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100948003A CN101627973B (zh) | 2009-08-05 | 2009-08-05 | 一种醋酸钙片及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100948003A CN101627973B (zh) | 2009-08-05 | 2009-08-05 | 一种醋酸钙片及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101627973A true CN101627973A (zh) | 2010-01-20 |
CN101627973B CN101627973B (zh) | 2011-11-16 |
Family
ID=41573369
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100948003A Active CN101627973B (zh) | 2009-08-05 | 2009-08-05 | 一种醋酸钙片及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101627973B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104606159A (zh) * | 2015-01-23 | 2015-05-13 | 永信药品工业(昆山)有限公司 | 一种醋酸钙药物组合物及其制备方法 |
CN107157975A (zh) * | 2017-05-25 | 2017-09-15 | 北京万鹏朗格医药科技有限公司 | 一种含醋酸钙的药物组合物及其制备方法 |
CN108097076A (zh) * | 2018-01-05 | 2018-06-01 | 上海裕英生物医药科技有限公司 | 一种醋酸钙的干燥方法 |
CN110279668A (zh) * | 2019-08-07 | 2019-09-27 | 山东创新药物研发有限公司 | 一种醋酸钙药物组合物及其制备方法和应用 |
CN113307734A (zh) * | 2021-04-16 | 2021-08-27 | 山东创新药物研发有限公司 | 一种醋酸钙原料及制剂的制备方法 |
CN113521045A (zh) * | 2021-07-08 | 2021-10-22 | 北京百美特生物制药有限公司 | 一种醋酸钙组合物及其制备方法、用途 |
-
2009
- 2009-08-05 CN CN2009100948003A patent/CN101627973B/zh active Active
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104606159A (zh) * | 2015-01-23 | 2015-05-13 | 永信药品工业(昆山)有限公司 | 一种醋酸钙药物组合物及其制备方法 |
CN107157975A (zh) * | 2017-05-25 | 2017-09-15 | 北京万鹏朗格医药科技有限公司 | 一种含醋酸钙的药物组合物及其制备方法 |
CN107157975B (zh) * | 2017-05-25 | 2020-07-10 | 北京万鹏朗格医药科技有限公司 | 一种含醋酸钙的药物组合物及其制备方法 |
CN108097076A (zh) * | 2018-01-05 | 2018-06-01 | 上海裕英生物医药科技有限公司 | 一种醋酸钙的干燥方法 |
CN110279668A (zh) * | 2019-08-07 | 2019-09-27 | 山东创新药物研发有限公司 | 一种醋酸钙药物组合物及其制备方法和应用 |
CN113307734A (zh) * | 2021-04-16 | 2021-08-27 | 山东创新药物研发有限公司 | 一种醋酸钙原料及制剂的制备方法 |
CN113521045A (zh) * | 2021-07-08 | 2021-10-22 | 北京百美特生物制药有限公司 | 一种醋酸钙组合物及其制备方法、用途 |
Also Published As
Publication number | Publication date |
---|---|
CN101627973B (zh) | 2011-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101627973B (zh) | 一种醋酸钙片及其制备方法 | |
JP5760069B2 (ja) | 高分子ヒドロゲルおよびその調製方法 | |
US5830884A (en) | Pharmaceutical products containing thermally-inhibited starches | |
CN107875136B (zh) | 一种阿莫西林药物制剂及其制备方法 | |
KR20170109587A (ko) | 높은 탄성 계수 및 흡수율로 결합되는 하이드로겔을 제조하는 방법 | |
CN101516403B (zh) | 口腔崩解片及其制备方法 | |
CN102973528B (zh) | 骨化三醇固体脂质分散体及其制备方法 | |
CN101999713A (zh) | 一种螺旋藻片及其制备方法 | |
CN101744852B (zh) | 刺五加泡腾片的制备方法及其产品 | |
CN103610677A (zh) | 一种瑞格列奈片剂及其制备方法 | |
CN102077955B (zh) | 可溶性魔芋膳食纤维片及其制作方法 | |
CN112315922B (zh) | 一种西咪替丁片的制备方法 | |
CN104116743A (zh) | 预防给药的叶酸药物组合物 | |
CN106727378A (zh) | 一种含有替格瑞洛主药的片剂组合物及其制备方法 | |
JP4774739B2 (ja) | 漢方エキス含有錠剤組成物およびその製造方法 | |
CN103110601B (zh) | 一种格列齐特胃漂浮片及其制备方法 | |
CN104721202A (zh) | 一种用于防治急性高原反应的药物 | |
CN101658482A (zh) | 低分子硫酸软骨素口服制剂及其制法和用途 | |
CN102895202A (zh) | 一种盐酸头孢他美酯分散片及其制备方法 | |
CN107028912A (zh) | 一种厄贝沙坦胶囊的制备方法 | |
CN103479593A (zh) | 一种奥美拉唑肠溶片的制备方法 | |
Meko et al. | Investigation into the use of acid modified millet (Pennisetum glaucum) starch mucilage as tablet binder | |
CN103432082A (zh) | 氨基葡萄糖组合物及其制备方法 | |
CN106924202A (zh) | 一种阿司匹林肠溶片及其制备工艺 | |
CN105193826A (zh) | 维生素d3预混料的制备方法及其制得的维生素d3预混料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Kunming Bangyu Pharmaceutical Co., Ltd. Assignor: Wang Bing Contract record no.: 2012530000034 Denomination of invention: Calcium acetate tablet and preparation method thereof Granted publication date: 20111116 License type: Exclusive License Open date: 20100120 Record date: 20120621 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161025 Address after: 650000, No. 2709, cultural road, Banqiao bridge, Guandu District, Yunnan, Kunming Patentee after: Kunming Bangyu Pharmaceutical Co., Ltd. Address before: 650033 Yunnan province Kunming city Kunming high tech Zone Jindingshan business service center building B building 3-5 Patentee before: Wang Bing |